A Practical Roadmap for Diagnosing and Treating DED, With Drs. Lisa Nijm and Vance Thompson

0.50 CME

15 MINS

SAVE

Overview

Provider Statement

This continuing medical education activity is provided by Vindico Medical Education

Support Statement

This activity is supported by educational grants from Alcon Vision, LLC, and Bausch + Lomb.

Target Audience

The intended audience for this activity is ophthalmologists and other health care professionals responsible for the overall management of patients with, or at risk for, ocular surface disease.

Learning Objectives

Upon successful completion of this activity, participants should be better able to:

Evaluate new methods and modalities for the diagnosis, assessment, and monitoring of ocular surface disease.
Differentiate current therapeutic strategies for their ability to optimize therapy, improve patient outcomes, and aid in prevention of ocular surface disease.
Review the treatment of ocular surface disease in special patient populations and in those with comorbidities.

Chief Medical Editor

Lisa M. Nijm, MD, JD
Founder, MDNegotiation.com
Founder, RealWorldOphthalmology.com
CEO, Women in Ophthalmology
Founder and Medical Director, Warrenville EyeCare and LASIK
Assistant Clinical Professor of Ophthalmology, University of Illinois Eye and Ear Infirmary
Chicago, IL

Faculty

Vance Thompson, MD
Professor of Ophthalmology
University of South Dakota, Sanford School of Medicine
Founder, Vance Thompson Vision
Sioux Falls, SD

Reviewer

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP

Accreditation

Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This enduring material is approved for 1 year from the date of original release, December 31, 2022, to December 30, 2023.

How to Participate in This Activity and Obtain CME Credit

To participate in this CME activity, you must read the objectives, answer the pretest questions, listen to the podcast, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 2 out of 3 of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate.

Disclosures

Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Relationship information is accurate at the time of content development.

Chief Medical Editor and Faculty report the following relationship(s)

Lisa M. Nijm, MD, JD
Advisor: Aerie, Alcon, Allergan, Bausch + Lomb, Bruder, Dompé, Johnson & Johnson Vision, Novartis, Ocular Therapeutix, Oyster Point, Rayner, Sun, TearLab, Zeiss
Speaker Contracted by Ineligible Company: Allergan, Bausch + Lomb, Oyster Point, Sun
Independent Research Contractor: Ocular Therapeutix
Individual Stocks and Stock Options: TearLab

Vance Thompson, MD
Consultant: AdOM, Alcon, Allergan, Bausch + Lomb, BRIM Biotechnology, CSO, Equinox, Eyedetec, EyeGate, Glaukos, iVeena, Johnson & Johnson Vision, Leica, Melt Pharmaceuticals, Oyster Point, Sight Sciences, Stuart Therapeutics, Tarsus Rx, TearClear, TearOptix, Thea, TherOptix, Veracity, Zeiss
Speaker for Ineligible Company: Alcon, Bausch + Lomb, Euclid Systems, eyeBrain, Glaukos, Johnson & Johnson Vision, Oyster Point, Rayner, RxSight, Zeiss
Independent Research Contractor: Alcon, Allergan, Equinox, EyeGate, Glaukos, Johnson & Johnson Vision, Melt Pharmaceuticals, Ocular Therapeutix, Ora, Rayner, RxSight, Sight Sciences, Zeiss
Individual Stocks and Stock Options: AdOM, Al Optics, Equinox, Euclid Systems, Eyedetec, EyeGate, Fontana Biosciences, iVeena, Melt Pharmaceuticals, Oyster Point, Sight Sciences, Stuart Therapeutics, Tarsus Rx, TearClear, TearOptix, TherOptix, Veracity

Reviewer reports the following relationship(s)

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.

Vindico Medical Education staff report the following relationship(s)

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Unlabeled and Investigational Usage

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)–approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.

ADA Compliance

In compliance with the Americans with Disabilities Act of 1990, we will make all reasonable efforts to accommodate persons with disabilities. A text-based transcript of this Podcast is available upon request. Requests should include the Podcast title and can be emailed to cme@vindicoCME.com. Requests will be honored within 3-5 business days.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2022 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.